Lista de obras - Maria J Pereira - Dominio Público Uruguay

A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss

artículo científico publicado en 2018

A case report of improved metabolic control after conversion from everolimus to cyclosporin A: role of adipose tissue mechanisms?

artículo científico publicado en 2014

Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study

artículo científico publicado en 2018

Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study

scientific article published on 01 August 2018

Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes

artículo científico publicado en 2020

Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes

artículo científico publicado en 2019

Calcineurin is an important factor involved in glucose uptake in human adipocytes.

artículo científico publicado en 2018

Characterization of brown adipose tissue in the human perirenal depot

artículo científico

Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents

artículo científico publicado en 2014

Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment

artículo científico publicado en 2014

Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year

artículo científico publicado en 2017

Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes

artículo científico publicado en 2016

Differences between men and women in the regulation of adipose 11β-HSD1 and in its association with adiposity and insulin resistance

artículo científico publicado en 2013

Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes

scientific article published on 28 December 2019

Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D

scientific article published on 01 July 2019

Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model.

artículo científico publicado en 2013

Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes

artículo científico publicado en 2009

Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity

artículo científico publicado en 2019

Estrogen interacts with glucocorticoids in the regulation of lipocalin 2 expression in human adipose tissue. Reciprocal roles of estrogen receptor α and β in insulin resistance?

scientific article published on 03 April 2019

Evaluation of reference genes for gene expression studies in human brown adipose tissue

artículo científico publicado en 2015

FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance

artículo científico publicado en 2014

FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes

artículo científico publicado en 2018

Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers

artículo científico publicado en 2018

Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes

artículo científico publicado en 2019

Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important factors

artículo científico publicado en 2016

Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes

scientific article published on 04 July 2019

Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue.

artículo científico publicado en 2016

Microdialysis and proteomics of subcutaneous interstitial fluid reveals increased galectin-1 in type 2 diabetes patients

artículo científico publicado en 2016

Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model

scientific article published on 22 January 2014

Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance.

artículo científico publicado en 2016

Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover

artículo científico publicado en 2018

Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction.

artículo científico publicado en 2018

Short and long term in vivo effects of Cyclosporine A and Sirolimus on genes and proteins involved in lipid metabolism in Wistar rats

artículo científico publicado en 2014

The TGR5 gene is expressed in human subcutaneous adipose tissue and is associated with obesity, weight loss and resting metabolic rate

artículo científico publicado en 2013

The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue

artículo científico publicado en 2012

mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes

artículo científico publicado en 2012

Lista de obras de Maria J Pereira

A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss

A case report of improved metabolic control after conversion from everolimus to cyclosporin A: role of adipose tissue mechanisms?

Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study

Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study

Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes

Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes

Calcineurin is an important factor involved in glucose uptake in human adipocytes.

Characterization of brown adipose tissue in the human perirenal depot

Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents

Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment

Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year

Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes

Differences between men and women in the regulation of adipose 11β-HSD1 and in its association with adiposity and insulin resistance

Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes

Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D

Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model.

Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes

Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity

Estrogen interacts with glucocorticoids in the regulation of lipocalin 2 expression in human adipose tissue. Reciprocal roles of estrogen receptor α and β in insulin resistance?

Evaluation of reference genes for gene expression studies in human brown adipose tissue

FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance

FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes

Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers

Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes

Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important factors

Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes

Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue.

Microdialysis and proteomics of subcutaneous interstitial fluid reveals increased galectin-1 in type 2 diabetes patients

Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model

Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance.

Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover

Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction.

Short and long term in vivo effects of Cyclosporine A and Sirolimus on genes and proteins involved in lipid metabolism in Wistar rats

The TGR5 gene is expressed in human subcutaneous adipose tissue and is associated with obesity, weight loss and resting metabolic rate

The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue

mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes